Matthew T. Keeney

LRRK2 activation in idiopathic Parkinson’s disease

Roberto Di Maio, Eric K. Hoffman, Emily M. Rocha et al. · Science Translational Medicine · 2018 · 580 citations · Full text

The Parkinson’s disease protein alpha-synuclein is a modulator of processing bodies and mRNA stability

Erinc Hallacli, Can Kayatekin, Sumaiya Nazeen et al. · Cell · 2022 · 154 citations · Full text

LRRK2 inhibition prevents endolysosomal deficits seen in human Parkinson's disease

Emily M. Rocha, Briana R. De Miranda, Sandra L. Castro et al. · Neurobiology of Disease · 2019 · 98 citations · Full text

Mitophagy, Cell Death, Synaptic Signaling +25

Transient exposure to rotenone causes degeneration and progressive parkinsonian motor deficits, neuroinflammation, and synucleinopathy

Amber D. Van Laar, Katherine R. Webb, Matthew T. Keeney et al. · npj Parkinson s Disease · 2023 · 60 citations · Full text

NADPH oxidase 2 activity in Parkinson's disease

Matthew T. Keeney, Eric K. Hoffman, Kyle Farmer et al. · Neurobiology of Disease · 2022 · 44 citations · Full text